2018-00506. Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc.  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 19, 2018.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR 0, appendix to subpart R.

    In accordance with 21 CFR 1301.33(a), this is notice that on November 10, 2017, Johnson Matthey Inc., Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania 19428 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

    Controlled substanceDrug codeSchedule
    Gamma Hydroxybutyric Acid2010I
    Amphetamine1100II
    Methylphenidate1724II
    Codeine9050II
    Oxycodone9143II
    Diphenoxylate9170II
    Hydrocodone9193II
    Meperidine9230II
    Methadone9250II
    Methadone intermediate9254II
    Morphine9300II
    Thebaine9333II
    Opium tincture9630II
    Start Printed Page 2216

    The company plans to manufacture the listed controlled substances in bulk for either internal use or for sale to its customers. Thebaine (9333) will be used to manufacture other controlled substances for sale in bulk to its customers.

    Start Signature

    Dated: January 4, 2018.

    Susan A. Gibson,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2018-00506 Filed 1-12-18; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
01/16/2018
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2018-00506
Dates:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 19, 2018.
Pages:
2215-2216 (2 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2018-00506.pdf